Nicholas Ralph Turman MD, Presenter: Nothing to Disclose

Shiliang Sun MD, Abstract Co-Author: Nothing to Disclose

Fadi Mohamad Youness MD, Abstract Co-Author: Nothing to Disclose

Sandeep T. Laroia MD, Abstract Co-Author: Nothing to Disclose

Mark Karwal, Abstract Co-Author: Nothing to Disclose

Thomas Collins, Abstract Co-Author: Nothing to Disclose

Leana A. Guerin MD, Abstract Co-Author: Nothing to Disclose

The purpose of this exhibit is to: 1. To demonstrate types of lipiodol deposition pattern on noncontrast CT performed one day after TACE and its predicting value for tumor destruction – correlated with pathology and imaging findings 2. Comparing the outcomes of the groups of patients with/without subsequent particle embolization  

To demonstrate types of lipiodol deposition pattern on noncontrast CT performed one day after TACE and its predicting value for tumor destruction – correlated with pathology and imaging findings      Full homogeneous deposition pattern within target tumor      Full heterogenous deposition pattern within target lesion      Partial geographic deposition defect pattern Also comparing the outcomes of the groups of patients with/without subsequent particle embolization 

http://abstract.rsna.org/uploads/2014/14003374/14003374_f5mz.pdf

Turman, N, Sun, S, Youness, F, Laroia, S, Karwal, M, Collins, T, Guerin, L, Implications of Lipiodol Deposition Pattern on Non-contrast CT Immediately After TACE: Correlation with Pathological Findings.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003374.html